Barbra Streisand Clarifies Ozempic IG Comment to Melissa McCarthy: ‘I Just Wanted to Pay Her a Compliment’ 

2 weeks ago
Please Share to your Social Media
Please Follow Naijamerit on Social Media

The EGOT member has since deleted her comment.

Barbra Streisand at the 30th Annual Screen Actors Guild Awards held at the Shrine Auditorium and Expo Hall on February 24, 2024 in Los Angeles, California.

Barbra Streisand at the 30th Annual Screen Actors Guild Awards held at the Shrine Auditorium and Expo Hall on Feb. 24, 2024 in Los Angeles, California. Michael Buckner for Variety

Barbra Streisand is explaining her thought process after sharing a since-deleted Instagram comment asking Melissa McCarthy if she’s on Ozempic.

It all started when McCarthy posted two snaps on IG on Monday (April 29) of herself attending the Center Theatre Group gala with Hairspray director Adam Shankman. “Pastels only to honor the incredible @matthewbourne13 at the @ctgla gala last night with this fella @adamshankman !!” she wrote in the caption. “Thiiiiis much closer to my dream of dancing on stage 💃🏻💚.”

“Give him my regards did you take Ozempic?” Streisand commented, eagle eyed fans noticed and theorized that the EGOT winner must have accidentally thought she was sending a direct message instead of a public comment. Ozempic is a diabetes and anti-obesity medication that has risen in popularity among influencers and celebrities in recent months.

Explore

Explore

See latest videos, charts and news

See latest videos, charts and news

Streisand soon deleted the comment, and took to her X profile to offer an explanation. “OMG – I went on Instagram to see the photos we’d posted of the beautiful flowers I’d received for my birthday,” she wrote. “Below them was a photo of my friend Melissa McCarthy who I sang with on my Encore album. She looked fantastic! I just wanted to pay her a compliment. I forgot the world is reading!”

See her post below.

Get weekly rundowns straight to your inbox

Sign Up

Read full article
Please Follow Naijamerit on Social Media
< Back | News content